Competitive Intelligence and Competitor Strategy

Interesting article in PharmaVoice in April 2012 – regarding Competitive Intelligence and Competitor Strategy.  The article rightly points out that Pharma is leaving good intel on the table –by not developing relationships and using them effectively; or by taking a very high-minded attitude to informal sources of intel (e.g. conversations overheard at airports); or with…

Details

Evidence matters… of course it does!

Ruairi O’Donnell writes in the March 2012 issue of Pharmaceutical Market Europe that evidence matters.  Of course it does. And particularly in market access activities, which is the context he addresses in his article. Some of the points he makes are very good: about payers as a group being a variety of different types of people…

Details